STRATASYS LTD. Q3 FY2025 earnings call

• Disciplined cost management enabled solid operating cash flow and EPS. Focus on operational excellence, customer partnerships, and executing strategy in key verticals like aerospace, defense, automotive, dental.
• Strong hardware sales in aerospace/defense with wins from Boeing, Embraer, Honeywell, etc. Participated in Trident Warrior 25, demonstrating distributed manufacturing. Partnership with large tech company for F3300 systems. Adoption of H350 by global pharma company. Extended partnership with Andretti Global.
• Key growth areas include aerospace/defense, dental, medical, tooling, and industrial machine components. Emphasis on localized manufacturing, supply chain mitigation, and sustainability.

Consolidated revenue for the third quarter was $137 million, down 2.1% year-over-year. Product revenue was $94.1 million (flat year-over-year), with system revenue $32.1 million (up from $31.7 million year-over-year) and consumables revenue $62 million (flat year-over-year). Service revenue was $42.9 million (down from $45.9 million year-over-year), with customer support revenue $29.3 million (down from $31 million year-over-year). GAAP gross margin was 41% (vs. 44.8% year-over-year), Non-GAAP gross margin was 45.3% (vs. 49.6% year-over-year). GAAP operating expenses were $78.8 million (57.5% of revenue), Non-GAAP operating expenses were $62 million (45.3% of revenue). GAAP net loss was $55.6 million ($0.65 per diluted share), Non-GAAP net income was $1.5 million ($0.02 per diluted share). Adjusted EBITDA was $5 million, and cash from operating activities was $6.9 million.

• Full-year 2025 revenue range: $550 million to $560 million.
• Non-GAAP gross margin range: 46.7% to 47%.
• Non-GAAP operating margin range: 1.5% to 2%.
• Adjusted EPS range: $0.13 to $0.16.
• Adjusted EBITDA range: $30 million to $32 million. Anticipate higher operating cash flow year-over-year.

• Forward-looking statements may differ from actual results due to risks in Stratasys Ltd.'s annual report Form 20-F, including factors affecting revenue, margins, and operational performance.

Q: Talk about the gross margin trajectory and when it might return to prior year levels A: Anticipate improvement in Q4 due to price increases to offset tariff impact, with continued improvement in 2026.

Q: Update on production applications sales cycles A: Same opportunities as before, with aerospace/defense and tooling as key focus areas, long sales cycles but seeing slight improvement.

Q: Consumables revenue trend A: Consumables expected to be stable or flip, with growth in higher-end manufacturing use cases driving increased material consumption.

Q: OpEx outlook A: Expect Q4 OpEx to trend slightly down from Q3, balancing cost management with investment in growth.

Q: Dental opportunity and timing A: Strong focus on dental with Chris Cabot's addition, targeting restorative dental and use cases with PolyJet and P3 technologies, with leading U.S. providers as customers.

Q: Future purchases from AI social media company A: Excited about potential, chosen for high-end FDM capabilities, with potential for manufacturing production parts leading to incremental software and product purchases.